RECRUITING

Support for Cancer Patients Awaiting News

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a behavioral trial study to pilot test a stress management intervention for people with cancer who are undergoing routine cancer scans. The study will involve two pilot testing phases. Initial feasibility will be determined in an Open Trial phase, to inform any needed revisions to the intervention and/or protocol prior to a Pilot Randomized Controlled Trial phase. The Open Trial phase is an unblinded, single-site, single-arm open trial (n=10). The Pilot randomized clinical trial (RCT) phase is an unblinded, single-site, feasibility pilot randomized controlled trial (n=50).

Official Title

Support for Cancer Patients Awaiting News (SCAN Study): Pilot Testing a Stress Management Program

Quick Facts

Study Start:2024-05-01
Study Completion:2025-04-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06199570

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Adult (ages 18 and older)
  2. 2. Comfortable speaking, reading, and writing English without an interpreter
  3. 3. Established diagnosis of Stage III-IV lung cancer (or extensive stage small cell lung cancer)
  4. 4. ECOG (Eastern Cooperative Oncology Group) performance status of 0 to 2
  5. 5. Receiving ongoing care from collaborating clinics with regular scans
  6. 6. Receiving systemic treatment for lung cancer
  7. 7. Endorse appointment- or scan-related stress on 4-item screen (using a modified Distress Thermometer item, a Fear of Progression scale item, an Impact of Events scale item, and an item from our prior study)
  8. 8. Willingness to use the study website
  1. 1. Moderate-to-severe cognitive impairment (per dementia diagnosis or cognitive screen)
  2. 2. Requires an interpreter for medical visits
  3. 3. Severe psychiatric illness (psychiatric hospitalization in the past year, or substance use disorder, bipolar disorder, or psychosis diagnosis)
  4. 4. Currently enrolled in hospice
  5. 5. Unable to complete study activities per oncology provider's judgment (e.g., due to fatigue)

Contacts and Locations

Study Contact

Amanda Khoudary, BA
CONTACT
2018803445
Amanda.Khoudary@hmh-cdi.org

Principal Investigator

Heather Derry-Vick, PhD
PRINCIPAL_INVESTIGATOR
Hackensack Meridian Health

Study Locations (Sites)

Amanda Khoudary
Hackensack, New Jersey, 07601
United States

Collaborators and Investigators

Sponsor: Hackensack Meridian Health

  • Heather Derry-Vick, PhD, PRINCIPAL_INVESTIGATOR, Hackensack Meridian Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-01
Study Completion Date2025-04-30

Study Record Updates

Study Start Date2024-05-01
Study Completion Date2025-04-30

Terms related to this study

Keywords Provided by Researchers

  • Stress management
  • Cancer related anxiety
  • Scan related anxiety
  • Advanced lung cancer

Additional Relevant MeSH Terms

  • Lung Cancer